François Bidault

Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria

Mélodie Tazdait, Laura Mezquita, J. Lahmar et al. · European Journal of Cancer · 2017 · 337 citations

Oncology, Medicine, Recist 1.1 +6

Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Khalil Saleh, Amaury Daste, Nicolas Martin et al. · European Journal of Cancer · 2019 · 180 citations

Medicine, Immune Checkpoint Inhibitors, Immunology +8

Evaluation of an atlas-based automatic segmentation software for the delineation of brain organs at risk in a radiation therapy clinical context

A. Isambert, F. Dhermain, François Bidault et al. · Radiotherapy and Oncology · 2008 · 153 citations

Neuro-oncology, Image Analysis, Engineering +14

18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer

Thomas Poisson, Désirèe Deandreis, Sophie Leboulleux et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 100 citations

Positron Emission Tomography, Engineering, Health Sciences +7

Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status

Dan Ou, Pierre Blanchard, Silvia Rosellini et al. · Oral Oncology · 2017 · 98 citations · Full text

Adaptive Radiotherapy, Advanced Head, Radiomics Signature +10